Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug aims to protect hearts after attack

NCT ID NCT03470441

Completed Disease control Sponsor: Faraday Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new medicine called FDY-5301 in 120 people having a severe heart attack (STEMI). Participants received either the drug or a placebo during a procedure to open blocked arteries. The main goal was to see if the drug could reduce dangerous heart rhythm problems and limit heart damage. The trial has been completed, and results will help decide if further testing is needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYOCARDIAL INFARCTION STEMI

Contacts and locations

Locations

  • Borsod-Abaúj-Zemplén Megyei Központi Kórház

    Miskolc, Hungary

  • Budai Irgalmasrendi Kórház

    Budapest, Hungary

  • Debreceni Egyetem Klinikai Központ, Kardiológiai és Szívsebészeti Klinika

    Debrecen, Hungary

  • Freeman Hospital

    Newcastle upon Tyne, Tyne and Wear, United Kingdom

  • Glenfield Hospital

    Leicester, Leicestershire, United Kingdom

  • Golden Jubilee National Hospital

    Glasgow, United Kingdom

  • KLINIKA KARDIOLOGII, 4 Wojskowy Szpital Kliniczny

    Wroclaw, Poland

  • Klinika Elektrokardiologii; Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodzi

    Lodz, Poland

  • Klinika Kardiologii Inwazyjnej; Centralny Szpital Kliniczny MSWiA w Warszawie

    Warsaw, Poland

  • Magyar Honvédség Egészségügyi Központ

    Budapest, Hungary

  • Miedziowe Centrum Zdrowia

    Lubin, Poland

  • Minneapolis Heart Institute

    Minneapolis, Minnesota, 55047, United States

  • Montefiore Medical Center

    The Bronx, New York, 10467, United States

  • New Cross Hospital

    Wolverhampton, West Midlands, United Kingdom

  • Ninewells Hospital and Medical School

    Dundee, United Kingdom

  • Royal Devon and Exeter Hospital Cardiology Department

    Exeter, Devon, United Kingdom

  • Royal Infirmary of Edinburgh

    Edinburgh, United Kingdom

  • Samodzielny Publiczny Specjalistyczny Szpital Zachodnii im. Jana Pawła II, Oddział Kardiologii Inwazyjnej

    Grodzisk Mazowiecki, Poland

  • Samodzielny Publiczny Specjalistyczny Szpital Zachodnii im. Jana Pawła II, Oddział Kardiologii Inwazyjnej

    Krakow, Poland

  • Samodzielny Publiczny Szpital Kliniczny Nr 7 Śląskiego Uniwersytetu Medycznego w Katowicach, Górnośląskie Centrum Medyczne im. Prof. Leszka Kieca., III Oddz. Kardiologii

    Katowice, Silesian Voivodeship, Poland

  • University of Oxford

    Oxford, Oxfordshire, United Kingdom

  • Wythenshawe Hospital

    Manchester, Greater Manchester, United Kingdom

  • Zala Megyei Szent Rafael Kórház

    Zalaegerszeg, Hungary

More trials for these conditions

Other studies related to the condition(s) this trial covers.